Weekly Investment Analysts’ Ratings Updates for Jazz Pharmaceuticals (JAZZ)
Several analysts have recently updated their ratings and price targets for Jazz Pharmaceuticals (NASDAQ: JAZZ): 5/15/2025 – Jazz Pharmaceuticals was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating. 5/7/2025 – Jazz Pharmaceuticals had its “overweight” rating reaffirmed by analysts at Piper Sandler. They now have a $147.00 price target on […]
Several analysts have recently updated their ratings and price targets for Jazz Pharmaceuticals (NASDAQ: JAZZ): 5/15/2025 – Jazz Pharmaceuticals was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating. 5/7/2025 – Jazz Pharmaceuticals had its “overweight” rating reaffirmed by analysts at Piper Sandler. They now have a $147.00 price target on […]
